Massive Losses for Intercell
Published: March 2, 2011; 00:00 · (Vindobona)
The Austrian pharmaceutical company today reported losses for 2010 amounting to € 255m. Operating cash flow has been strongly negative too.
Massive Losses for Intercell / Picture: © Vindobona.org
Today Intercell AG (VSE: ICLL) announced its financial results for Q4 and the preliminary results for the full financial year 2010 and presented an update on the Company’s development programs.
In 2010, Intercell experienced a serious backdrop in its development. Due to a cancelled program for the development of vaccines, the company had to…
or Log In
Fast News Search